Loading stock data…
CLX
$87.11-9.33 (-9.67%)
Market ClosedLast close May 1
The Clorox Company manufactures and markets consumer and professional products worldwide.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
The Clorox Company in the Consumer Defensive sector is trading at $87.11. The stock is currently near its 52-week low of $86.01, remaining 21.1% below its 200-day moving average. Technical signals show oversold RSI of 24 and bearish MACD signal, explaining why CLX maintains its current current market pressure. The Whystock Score of 40/100 suggests a balanced risk-reward profile.
Ecosystem Influences
Oversold momentum (RSI 24) — potential for technical mean-reversion
Long-term trend bearish (Price vs 200-day SMA)
Macro-economic sensitivity to interest rate and inflation shifts
Loading Financials...
Peer Comparison
Whystock Valuation Model
Whystock fair value is estimated using a trailing P/E model adjusted for return on equity: Fair P/E = 18 + (ROE × 20). Fair Value = (Current Price ÷ Trailing P/E) × Fair P/E. A base P/E of 18 represents a typical market multiple, scaled upward for companies that earn high returns on equity. The result is a theoretical "normalised" price — not a price target or investment advice. Large deviations are common for high-growth or loss-making companies.
Current Price$87.11
Potential Downside
798.2%
Whystock Fair Value$-608.21
Price
UndervaluedFair ValueOvervalued
Simplified model based on P/E and ROE. Not a substitute for full valuation analysis. Data may be delayed. See our Terms.
Analyst Consensus17 analysts
Hold
Mean target$108.24+24.3%
Range$83.00 – $163.00
Fundamentals
The Clorox Company manufactures and markets consumer and professional products worldwide. The company operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers home care clean...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$11.81B
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
15.98
Beta
Defensive asset. Lower volatility than the S&P 500.
0.65
Div Yield
Strong income play. Yield provides a meaningful total return floor.
4.27%
ROE
Average efficiency. Growth may require heavy reinvestment.
-648.00%
Volume
Today's trading volume
13.23M
Recent News
Is The Clorox Company (CLX) A Good Stock To Buy Now?
Is CLX a good stock to buy? We came across a bullish thesis on The Clorox Company on DividendInvestor’s Substack. In this article, we will summarize the bulls’ thesis on CLX. The Clorox Company’s share was trading at $96.66 as of April 27th. CLX’s trailing and forward P/E were 15.82 and 14.01 respectively according to Yahoo Finance. […]
CLX Q1 Deep Dive: Margin Gains Offset by Cautious Outlook and Guidance Reduction
Consumer products giant Clorox (NYSE:CLX) met Wall Street’s revenue expectations in Q1 CY2026, but sales were flat year on year at $1.67 billion. Its non-GAAP profit of $1.64 per share was 6.1% above analysts’ consensus estimates.
Why Clorox (CLX) Shares Are Getting Obliterated Today
Shares of consumer products giant Clorox (NYSE:CLX) fell 9.1% in the morning session after the company reported mixed first-quarter results and lowered its full-year profit forecast.
3 Profitable Stocks That Concern Us
Not all profitable companies are built to last - some rely on outdated models or unsustainable advantages. Just because a business is in the green today doesn’t mean it will thrive tomorrow.
Why Clorox (CLX) Is Down 11.7% After Cutting 2026 Outlook Amid GOJO Dilution And Inflation
In late April 2026, The Clorox Company reported third‑quarter fiscal 2026 results with sales of US$1,670 million, net income of US$187 million, and slightly higher earnings per share while also filing a shelf registration for new debt securities. Despite meeting revenue expectations and modestly improving earnings, Clorox cut its full‑year sales and profit outlook amid inflation, supply chain pressures, and initial dilution from the GOJO acquisition, pointing to a more challenging near‑term...